Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/23112
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | RATAJCZAK, Jessica | - |
dc.contributor.author | HILKENS, Petra | - |
dc.contributor.author | GERVOIS, Pascal | - |
dc.contributor.author | WOLFS, Esther | - |
dc.contributor.author | Jacobs, Reinhilde | - |
dc.contributor.author | LAMBRICHTS, Ivo | - |
dc.contributor.author | BRONCKAERS, Annelies | - |
dc.date.accessioned | 2017-02-13T12:54:40Z | - |
dc.date.available | 2017-02-13T12:54:40Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | PLoS One, 11(12) (Art N° e0167807) | - |
dc.identifier.issn | 1932-6203 | - |
dc.identifier.uri | http://hdl.handle.net/1942/23112 | - |
dc.description.abstract | Periodontal ligament stem cells (PDLSCs) represent a good source of multipotent cells for cell-based therapies in regenerative medicine. The success rate of these treatments is severely dependent on the establishment of adequate vasculature in order to provide oxygen and nutrients to the transplanted cells. Pharmacological preconditioning of stem cells has been proposed as a promising method to augment their therapeutic efficacy. In this study, the aim was to improve the intrinsic angiogenic properties of PDLSCs by in vitro pretreatment with deferoxamine (DFX; 100μM), fibroblast growth factor-2 (FGF-2; 10ng/mL) or both substances combined. An antibody array revealed the differential expression of several proteins, including vascular endothelial growth factor (VEGF) and placental growth factor (PlGF). ELISA data confirmed a 1.5 to 1.8-fold increase in VEGF for all tested conditions. Moreover, 48 hours after the removal of DFX, VEGF levels remained elevated (1.8-fold) compared to control conditions. FGF-2 and combination treatment resulted in a 5.4 to 13.1-fold increase in PlGF secretion, whereas DFX treatment had no effect. Furthermore, both PDLSCs as pretreated PDLSCs induced endothelial migration. Despite the significant elevated VEGF levels of pretreated PDLSCs, the induced endothelial migration was not higher by pretreated PDLSCs. We find that the observed induced endothelial cell motility was not dependent on VEGF, since blocking the VEGFR1-3 with Axitinib (0.5nM) did not inhibit endothelial motility towards PDLSCs. Taken together, this study provides evidence that preconditioning with DFX and/or FGF-2 significantly improves the angiogenic secretome of PDLSCs, in particular VEGF and PlGF secretion. However, our data suggest that VEGF is not the only player when it comes to influencing endothelial behavior by the PDLSCs. | - |
dc.description.sponsorship | : This research was supported by grants to Ivo Lambrichts, Reinhilde Jacobs and Jessica Ratajczak from the Research Foundation-Flanders (‘Fonds Wetenschappelijk onderzoek Vlaanderen FWO’, grant n˚ G089213N). Annelies Bronckaers and Petra Hilkens are postdoctoral fellows of the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. | - |
dc.language.iso | en | - |
dc.rights | © 2016 Ratajczak et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | - |
dc.title | Angiogenic Capacity of Periodontal Ligament Stem Cells Pretreated with Deferoxamine and/or Fibroblast Growth Factor-2. | - |
dc.type | Journal Contribution | - |
dc.identifier.issue | 12 | - |
dc.identifier.volume | 11 | - |
local.format.pages | 16 | - |
local.bibliographicCitation.jcat | A1 | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
local.bibliographicCitation.artnr | e0167807 | - |
dc.identifier.doi | 10.1371/journal.pone.0167807 | - |
dc.identifier.isi | 000389587100200 | - |
item.validation | ecoom 2018 | - |
item.contributor | RATAJCZAK, Jessica | - |
item.contributor | HILKENS, Petra | - |
item.contributor | GERVOIS, Pascal | - |
item.contributor | WOLFS, Esther | - |
item.contributor | Jacobs, Reinhilde | - |
item.contributor | LAMBRICHTS, Ivo | - |
item.contributor | BRONCKAERS, Annelies | - |
item.accessRights | Open Access | - |
item.fullcitation | RATAJCZAK, Jessica; HILKENS, Petra; GERVOIS, Pascal; WOLFS, Esther; Jacobs, Reinhilde; LAMBRICHTS, Ivo & BRONCKAERS, Annelies (2016) Angiogenic Capacity of Periodontal Ligament Stem Cells Pretreated with Deferoxamine and/or Fibroblast Growth Factor-2.. In: PLoS One, 11(12) (Art N° e0167807). | - |
item.fulltext | With Fulltext | - |
crisitem.journal.issn | 1932-6203 | - |
crisitem.journal.eissn | 1932-6203 | - |
Appears in Collections: | Research publications |
SCOPUSTM
Citations
9
checked on Sep 5, 2020
WEB OF SCIENCETM
Citations
19
checked on Apr 30, 2024
Page view(s)
90
checked on Aug 31, 2022
Download(s)
110
checked on Aug 31, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.